Gene therapy builds CAR-T cells inside the body to fight myeloma
Disease control
Recruiting now
This early-stage study tests a new gene therapy called KLN-1010 for people with multiple myeloma that has come back or not responded to treatment. Instead of removing cells and engineering them in a lab, this therapy delivers a gene directly into the body to create cancer-fightin…
Phase: PHASE1 • Sponsor: Kelonia Therapeutics, Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC